Every Python developer knows some or all of these libraries, because they’re stable, reliable, and excellent at what they do.

Soligenix has scrapped its cutaneous T-cell lymphoma (CTCL) program in the wake of a phase 3 setback, leaving the biotech focused on another rare disease prospect and considering strategic ...

The power of Python trumps Excel workbooks.

Jeethu Joseph and Mohanlal’s Drishyam 3 is on a record-breaking spree. It has concluded its opening week on a highly favorable note. The Malayalam action thriller has surpassed the global lifetime of ...

Since Nvidia announced its massive earnings surge in May 2023, the semiconductor industry has dominated the tech sector and the overall US stock market. The AI tide isn’t lifting all boats. Software ...

Protecting Tunisia's national economy and population from climate disruptions requires financing estimated at $ 29 billion for the period 2026-2035, accounting for 53% of the total financing needs of ...

Use these eight AI prompts to create clearer charts, graphs, and data visualizations across ChatGPT, Gemini, Claude, Grok, and other AI tools.

Slay the Spire 2 has remained in first place on the Steam Weekly Top Sellers chart (excluding revenue generated by free games) for Week 12, 2026, which ended March 17, 2026. There were two new ...

3 Doors Down appears on Billboard's Top Streaming Albums chart for the first time as The Greatest Hits debuts, while the band earns another No. 1 on another list. BERLIN, GERMANY - OCTOBER 19 Singer ...

Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...

What are you looking at? It’s the arc of US stock market history over the past century, expansions in blue, downturns in magenta, recoveries in aquamarine. Expansions are defined as the period after ...

One of the assets shelved by Eli Lilly is a gene therapy for dementia, which it obtained in its $1.04-billion acquisition of Prevail Therapeutics in late 2020. As it works to expand its GLP-1 ...